Analyst Ratings for Nektar Therapeutics (NKTR)
NKTR Rating Summary
NKTR Price Target Summary
- Highest: $192.00 (Piper Sandler)
- Lowest: $65.00 (JPMorgan)
- Average: $145.90
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$145.90 (+106.5%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
Avg. $ Target:
$145.90 (+106.5%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/22/2026 | TD Cowen | Tara Bancroft | New Coverage | Buy (N/A) |
N/A (N/A) |
74.53 (70.65) |
-5.21% | Details |
| 8/21/2026 | JPMorgan | Jessica Fye | New Coverage | Neutral (N/A) |
65.00 (N/A) |
76.08 (70.65) |
-7.14% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
